FDA Inspection 1290034 — Sreenivasa R. Chandana, M.D., Ph.D.
The FDA completed an inspection of Sreenivasa R. Chandana, M.D., Ph.D. on October 16, 2025 in Grand Rapids, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 16, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Grand Rapids, MI (United States)
Additional Details
Clinical Investigator (CI)